Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma - An Infrequent Event: Elucidation of Risk Factors and Management Implications Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Deoxycytidine
  • Liver Neoplasms
  • Pancreatic Neoplasms
  • Peritoneal Neoplasms
  • Pneumonia

abstract

  • GRP is relatively uncommon but incurs significant morbidity. Potential risk factors include advanced-stage disease, along with smoking and alcohol consumption and possibly underlying lung disease. We recommend a high level of clinical alertness regarding the diagnosis, early pulmonary referral, and cessation of gemcitabine on suspicion of GRP.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4981480

Digital Object Identifier (DOI)

  • 10.1016/j.clcc.2015.08.003

PubMed ID

  • 26395520

Additional Document Info

start page

  • 24

end page

  • 31

volume

  • 15

number

  • 1